Materna Medical is focused on developing innovative solutions for women's pelvic health, specifically addressing common conditions such as vaginismus and pelvic floor injuries. Their flagship product, Milli, is a unique vaginal and pelvic floor dilator that features adjustable sizing, allowing women to gradually expand the vagina in one-millimeter increments. This design aims to alleviate discomfort associated with vaginismus and related dyspareunia, and it has received FDA clearance for its intended use. Launched in 2019, Milli is marketed through a direct-to-consumer approach as well as referrals from healthcare professionals, making it accessible for women seeking to improve their intimate health.

In addition to Milli, Materna Medical is developing Materna Prep, a clinical-stage device designed to reduce pelvic floor injuries during childbirth. This product is currently undergoing clinical trials, with promising preliminary results indicating a 60% reduction in pelvic floor injuries for first-time mothers who deliver vaginally. Given that a significant percentage of women experience incontinence and prolapse symptoms by age 55, Materna Prep aims to address these issues proactively during childbirth. The company’s commitment to empowering women in their pelvic health journey has garnered recognition, including being named a finalist for the World Changing Ideas 2021 Award by Fast Company.

United States

Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical's mission is to empower women to protect their pelvic health.

Materna Medical

Company Details